Cleanroom Technology Demand in Europe Led by High Infectious Disease Burden

The European Centre for Disease Prevention and Control (ECDC) estimated that 104,765 new cases of human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) were recorded in 2020 in member states of the European Union (EU). Additionally, the ECDC stated that 49,752 cases of tuberculosis (TB) were reported in EU countries in 2019. Further, the World Health Organization (WHO) estimates that nearly 14 diarrhea deaths are recorded in the European region each day, owing to inadequate water sanitation hygiene (WaSH).

According to P&S Intelligence, the market revenue stood at $1,126.6 million in 2017, and it will reach $1,701.8 by 2023. The rising prevalence of infectious diseases will increase patient footfall in healthcare facilities, which, in turn, will augment the consumption of cleanroom consumables, such as disinfectants and gloves, in the region.

In addition to healthcare facilities such as hospitals, the biotechnology, medical device, and pharmaceutical industries, academic institutes, and research laboratories are also the prominent users of cleanroom technology in Europe. In the coming years, the pharmaceutical sector will require a considerable amount of cleanroom technology-based products, due to the rising focus of pharma companies on research and development (R&D) of new drugs. Pharmaceutical companies use hardwall cleanrooms, which are primarily designed for research activities.

The product segment of the European cleanroom technology market is divided into consumables and equipment. Under this segment, the consumables category accounted for a larger market share during the historical period (2013–2017), on account of the extensive use of cleanroom consumables in hospitals, and semiconductor, medical device, pharmaceutical, and biotechnology companies to maintain a sterile environment. This category is further bifurcated into safety (gloves, apparel, and others), and cleaning (wipes, vacuum systems, disinfectants, and others).

Geographically, Germany accounted for the largest share in the European cleanroom technology market in the historical years, and it is expected to continue this trend throughout the forecast years as well. This can be attributed to the presence of numerous key market players, existence of a strong medical device industry, and largescale adoption of cleanroom products in biotechnology and pharmaceutical companies in the country. Whereas, the market in France is expected to witness the fastest growth during the forecast period, primarily on account of the improving healthcare infrastructure, rising cases of infectious diseases, and flourishing medical devices and pharmaceutical sectors in the nation.